Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0LR0R
|
||||
Former ID |
DAP001070
|
||||
Drug Name |
Methdilazine
|
||||
Synonyms |
Disyncram; Methdilazinum; Methodilazine; Metodilazina; Tacaryl; Tacazyl; Tacryl; Methilazine hydrochloride; Methdilazine (INN); Methdilazinum [INN-Latin]; Metodilazina [INN-Spanish]; Tacaryl (TN); Methdilazine [USAN:INN:BAN]; 10-((1-Methyl-3-pyrrolidinyl)methyl)phenothiazine; 10-((1-methyl-3-pyrrolidinyl)methyl)-10H-phenothiazine; 10-[(1-Methylpyrrolidin-3-yl)methyl]phenothiazine; 10-[(1-methylpyrrolidin-3-yl)methyl]-10H-phenothiazine
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antihistamines
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C18H20N2S
|
||||
InChI |
InChI=1S/C18H20N2S/c1-19-11-10-14(12-19)13-20-15-6-2-4-8-17(15)21-18-9-5-3-7-16(18)20/h2-9,14H,10-13H2,1H3
|
||||
InChIKey |
HTMIBDQKFHUPSX-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 1982-37-2
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9384, 135654, 647047, 7593023, 8161076, 10319677, 10512529, 11405746, 14751550, 29282717, 46505472, 47206710, 48035414, 48259508, 48416241, 49855141, 57328680, 79551326, 85209817, 103770942, 104335139, 117404375, 128111044, 131342044, 134338327, 134982817, 137101853, 141522707, 160964241, 176262319, 178103805, 179116778, 184528625, 223440310, 224019337, 226492957, 249964340
|
||||
SuperDrug ATC ID |
R06AD04
|
||||
SuperDrug CAS ID |
cas=001982372
|
||||
Target and Pathway | |||||
Target(s) | Histamine H1 receptor | Target Info | Antagonist | [537703] | |
PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
References | |||||
Ref 542247 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7231). | ||||
Ref 550689 | Drug information of Methdilazine, 2008. eduDrugs. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.